Solution: Educate investors with a 3D animation about how MC1101 is delivered to the back of the eye and increases blood-flow which removes debris and toxins, and thus prevents rupturing of the macula to stop the progression of dry macular degeneration.
ROI: MacuClear secured the desired amount of investment funding, as well as receiving the Texas Emerging Technology Fund totaling $1 million dollars.
MacuCLEAR's technology is complex to explain. Amerra was very effective creating an animation that helped visualize our mechanism of action that was anatomically correct and easy to understand. They caught the "vision" early and responded to minor edits quickly. Their work helped us immensely in our fund raising efforts.
